首页> 外文期刊>Biotechnology and Applied Biochemistry >Characterization of a single-chain variable fragment (scFv) antibody directed against the human asialoglycoprotein receptor
【24h】

Characterization of a single-chain variable fragment (scFv) antibody directed against the human asialoglycoprotein receptor

机译:针对人去唾液酸糖蛋白受体的单链可变片段(scFv)抗体的表征

获取原文
获取原文并翻译 | 示例
       

摘要

To obtain scFv (single-chain variable fragment) against human ASGPR (asialoglycoprotein receptor), a human non-immune phage antibody library was screened with the recombinant CRD (carbohydrate recognition domain) of rCRDHI (the HI subunit of human ASGPR). Anti-rCRDHI phage clones were obtained after four rounds of screening with rCRDHI-coated immunotubes and single positive colonies were further selected with the expressed thioredoxin-His-S tag of the wild-type pET32c. Two specific anti-rCRDHI phage clones (named C1 and C2) were transfected into Escherichia coli HB2151 and induced for secreted expression of scFv antibody. The purified anti-rCRDHI C1and C2 single-chain antibodies were characterized by immunoblotting and immunohistochemistry. Both antibodies were found to specifically recognize denatured and native forms of the ASGPR and thus could potentially be used as targeting molecules for gene therapy of hepatocellular carcinoma or other liver diseases.
机译:为了获得针对人ASGPR(亚糖蛋白受体)的scFv(单链可变片段),用rCRDHI(人ASGPR的HI亚基)的重组CRD(碳水化合物识别域)筛选了人非免疫噬菌体抗体库。在用rCRDHI包被的免疫管进行四轮筛选后获得抗rCRDHI噬菌体克隆,并用野生型pET32c的表达的硫氧还蛋白-His-S标签进一步选择单个阳性菌落。将两个特定的抗rCRDHI噬菌体克隆(分别称为C1和C2)转染到大肠杆菌HB2151中,并诱导其分泌表达scFv抗体。纯化的抗rCRDHI C1和C2单链抗体通过免疫印迹和免疫组织化学表征。发现这两种抗体都可以特异性识别ASGPR的变性形式和天然形式,因此有可能被用作肝细胞癌或其他肝病基因治疗的靶向分子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号